Tinlarebant is the first therapeutic candidate to demonstrate clinical efficacy in a global Phase 3 trial for Stargardt ...
Objective To develop and validate a 10-year predictive model for cardiovascular and metabolic disease (CVMD) risk using ...
Process Technology (Ultrafiltration, Microfiltration, Nanofiltration), Application (Pharmaceutical Filtration, Hemodialysis, ...
You'll be more productive if you can see what you need to do, and when you need to do it. This assessment and productivity tool is named for former president Dwight Eisenhower, who once quoted Dr. J.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback